June 2023 in numbers
NHS community prescribing in England (Prescription Cost Analysis).
102,239,576items
Dispensed in June 2023
NHSBSA Prescription Cost Analysis
£941,490,663
Net ingredient cost, June 2023
NHSBSA PCA
Most-dispensed medicines
Download full month (CSV)| Medicine | Items | Net ingredient cost |
|---|---|---|
| Atorvastatin | 5,381,754 | £9,531,841 |
| Amlodipine | 3,140,393 | £3,189,074 |
| Omeprazole | 3,046,977 | £12,509,330 |
| Lansoprazole | 2,918,512 | £4,087,759 |
| Levothyroxine sodium | 2,889,291 | £4,560,279 |
| Ramipril | 2,820,212 | £4,331,787 |
| Bisoprolol fumarate | 2,424,662 | £2,244,050 |
| Colecalciferol | 2,257,470 | £8,778,972 |
| Metformin hydrochloride | 2,142,840 | £7,268,145 |
| Sertraline hydrochloride | 1,963,640 | £3,456,077 |
| Salbutamol | 1,835,568 | £5,605,970 |
| Aspirin | 1,722,272 | £1,653,343 |
Biggest risers
Largest month-on-month rise in items (medicines above 10,000 items).
| Medicine | Items | Change |
|---|---|---|
| Sodium cromoglicate | 121,926 | +59.7% |
| Olopatadine | 39,434 | +56.4% |
| Typhoid | 43,379 | +41.0% |
| Hepatitis A | 30,643 | +38.6% |
| Medroxyprogesterone acetate | 38,463 | +30.2% |
| Fexofenadine hydrochloride | 672,903 | +28.2% |
| Oral rehydration salts | 16,460 | +23.6% |
| Neomycin sulfate | 45,374 | +23.1% |
Biggest fallers
Largest month-on-month fall in items.
| Medicine | Items | Change |
|---|---|---|
| Influenza | 81,418 | −30.4% |
| Adrenaline | 38,449 | −15.7% |
| Amoxicillin | 656,572 | −11.8% |
| Phenoxymethylpenicillin (Penicillin V) | 213,948 | −10.4% |
| Progesterone | 146,006 | −9.7% |
| Doxycycline hyclate | 281,345 | −9.6% |
| Metronidazole | 24,784 | −8.2% |
| Clarithromycin | 147,714 | −5.4% |